CTC
AMED

Cetera Trust Company’s Amedisys AMED Stock Holding History

Cetera Trust Company’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,785
Closed -$176K – 354
2025
Q2 		$176K Sell
1,785
-30
-2% -$2.84K 0.1% 177
2025
Q1 		$168K Hold
1,815
– – 0.11% 174
2024
Q4 		$165K Buy
1,815
+5
+0.3% +$459 0.11% 175
2024
Q3 		$175K Hold
1,810
– – 0.11% 184
2024
Q2 		$166K Hold
1,810
– – 0.1% 179
2024
Q1 		$167K Sell
1,810
-450
-20% -$42.2K 0.1% 183
2023
Q4 		$215K Buy
+2,260
New +$211K 0.13% 144

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Cetera Trust Company's AMED Position: Q3 2025 in Review

Cetera Trust Company sold out of Amedisys (AMED) in Q3 2025, closing a stake of 1,785 shares — an estimated $176K sold.

Cetera Trust Company first reported a position in AMED in Q4 2023 and held it in 7 quarters. The position peaked at $215K in Q4 2023. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Cetera Trust Company reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Cetera Trust Company sold 1,785 Amedisys shares in Q3 2025, an estimated $176K.
  • Cetera Trust Company first reported a position in Amedisys in Q4 2023 and held it in 7 quarters.
  • Cetera Trust Company's Amedisys position peaked at $215K in Q4 2023.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Cetera Trust Company's 13F filing for Q3 2025, filed 13 Nov 2025.